Our CEO dr. Marco Quarta will be speaking along with other leaders in the Biotech, Pharma and Ventures at BIO International Convention on the panel https://lnkd.in/gMKxRzHZ. We hope to see you there.
I am thrilled to announce that I will be speaking at BIO International Convention 2024, representing Rubedo Life Sciences. This year, I am honored to share the stage with a remarkable group of panelists including Hanadie Yousef founder and CEO at Juvena Therapeutics, Robert Gould at operating partner Khosla Ventures, Cristina Ghenoiu, Ph.D. partner at Mubadala, Simone Fantaccini, MD, MBA CSO and Head of Medical Affairs at Novartis, and moderator Brian Gormley Special Writer at The Wall Street Journal. At Rubedo, we are dedicated to developing the next generation of selective medicine targeting cellular senescence, underlying driver of chronic diseases. We are on the verge of entering the clinic soon with our first program focusing on chronic inflammatory skin conditions, paving the way for expansion into other tissues and organs across various therapeutic areas. It is truly exciting to witness companies such as Rubedo and Juvena pioneering in the field of Longevity Therapeutics, moving from specific indications to broader and multiple therapeutic areas. Special Kudos to Ali Siam, Rubedo CBO, who is the brilliant mind behind this, promoter and organizer of this amazing Panel. Thank you. For more information about the panel and details, you can visit the link below: https://lnkd.in/gwn-iY4q